As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Integrating Patient-Reported Outcomes Into Cancer Symptom Management Clinical Trials Supported by the National Cancer Institute–Sponsored Clinical Trials Networks The purpose of this article is to ...
A 55-year-old Caucasian woman noted a palpable lump in her left breast in August 2008. Diagnostic breast imaging revealed a 1.6 cm x 1.2 cm x 1.0 cm spiculated mass corresponding to the area of ...
Many oral drugs show a high variability in pharmacokinetic exposure, and, for drugs with exposure related to efficacy, therapeutic drug monitoring can help optimize exposure in individual patients.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results